Strategies for Upstream Intensification

Overview


Strategies-for-Upstream-Intensification.png

The Facility of the Future represents a transformation in how biologics are developed and manufactured.

This white paper describes how upstream intensification will enable this revolution by significantly driving down costs through an increase in volumetric productivity.

Indeed, upstream process intensification has the potential to accelerate protein production and increase protein quality. Perfusion based strategies are increasingly leveraged for this intensification as they deliver speed, productivity, flexibility and reliability… Read now!

This content is provided by Take the Right Path Upstream with MilliporeSigma, and any views and opinions expressed do not necessarily reflect those of Biopharma-Reporter.com

Download Now


Related Resources

Monitoring SARS-CoV-2 interaction with ACE2

Monitoring SARS-CoV-2 interaction with ACE2

Content provided by Take the Right Path Upstream with MilliporeSigma

White Paper

In this technical note, we investigate the interactions between the following: The spike glycoprotein binding with ACE2, Spike glycoprotein and anti-spike antibodies (mAb/ pAb), The spike glycoprotein binding with mAb/pAb to inhibit the interaction with ACE2

Accelerating Cell Line and Process Development

Accelerating Cell Line and Process Development

Content provided by Take the Right Path Upstream with MilliporeSigma

White Paper

Development of a high-producing cell line supported by a robust upstream process are critical early steps in the production of monoclonal antibodies (mAbs). Optimization of this upstream workflow is essential to deliver a sufficiently high titer to...

Supplier Info Centre

Take-the-Right-Path-Upstream-with-MilliporeSigma.png

For more product information visit Take the Right Path Upstream with MilliporeSigma.